Come up with a name for your new list and we'll add to it:
Alfama raised a round of funding on July 14, 2006. Investors include
Beta Capital Sociedade de Capital de Risco S.A..
Alfama specializes in the development of Carbon Monoxide-Releasing Molecules (CORMs) for therapy. The company produces CORMs and obtained exceptional results in various animal models of chronic and ac…